Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 19 02 2020
accepted: 16 05 2020
pubmed: 27 5 2020
medline: 14 9 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

How to prevent recurrences after a first venous thromboembolic (VTE) event in elderly patients is still an open issue, especially because of the high bleeding risk of anticoagulation in these patients. The placebo-controlled "Jason" study aims at assessing the efficacy and safety for secondary VTE prevention in elderly patients of oral Sulodexide (Vessel

Identifiants

pubmed: 32451933
doi: 10.1007/s11739-020-02381-5
pii: 10.1007/s11739-020-02381-5
pmc: PMC7952285
doi:

Substances chimiques

Anticoagulants 0
Glycosaminoglycans 0
Placebos 0
glucuronyl glucosamine glycan sulfate 75HGV0062C

Banques de données

ClinicalTrials.gov
['NCT04257487']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

359-368

Références

J Thromb Haemost. 2017 Oct;15(10):1963-1970
pubmed: 28762665
Circulation. 2011 Aug 16;124(7):824-9
pubmed: 21810658
N Engl J Med. 2010 Dec 23;363(26):2499-510
pubmed: 21128814
Am J Med. 2014 Jun;127(6):530-7.e3
pubmed: 24561112
N Engl J Med. 2013 Feb 21;368(8):699-708
pubmed: 23216615
Arch Intern Med. 1998 Mar 23;158(6):585-93
pubmed: 9521222
Circulation. 2015 Nov 17;132(20):1891-7
pubmed: 26408273
Thromb Haemost. 2000 May;83(5):657-60
pubmed: 10823257
Intern Emerg Med. 2020 Apr;15(3):453-462
pubmed: 31691119
Thromb Haemost. 2008 Nov;100(5):780-8
pubmed: 18989521
J Thromb Haemost. 2015 Nov;13(11):2119-26
pubmed: 26764429
Blood. 2014 Jul 10;124(2):196-203
pubmed: 24879813
Chest. 2016 Feb;149(2):315-352
pubmed: 26867832
CMAJ. 2003 Jan 21;168(2):183-94
pubmed: 12538548
Medicine (Baltimore). 2009 Nov;88(6):366-370
pubmed: 19910751
Am J Med. 2018 Jun;131(6):703.e7-703.e16
pubmed: 29307536
Am J Med. 2017 Feb;130(2):198-206
pubmed: 27742261
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
N Engl J Med. 2003 Sep 25;349(13):1247-56
pubmed: 14507950
N Engl J Med. 2017 Mar 30;376(13):1211-1222
pubmed: 28316279
N Engl J Med. 2013 Aug 29;369(9):799-808
pubmed: 23808982
Thromb Haemost. 2009 Jun;101(6):1112-8
pubmed: 19492156
N Engl J Med. 2012 Apr 5;366(14):1287-97
pubmed: 22449293
Thromb Haemost. 1996 Dec;76(6):1102-7
pubmed: 8972038
J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):977-81
pubmed: 25665832
Circulation. 1993 Oct;88(4 Pt 1):1730-5
pubmed: 8403319
J Thromb Thrombolysis. 2016 Jan;41(1):3-14
pubmed: 26780736
J Thromb Haemost. 2005 Apr;3(4):692-4
pubmed: 15842354
Blood. 2014 Sep 18;124(12):1968-75
pubmed: 24963045

Auteurs

Gualtiero Palareti (G)

Arianna Anticoagulazione" Foundation, Via Paolo Fabbri 1/3, 40138, Bologna, Italy. gualtiero.palareti@unibo.it.

Cristina Legnani (C)

Arianna Anticoagulazione" Foundation, Via Paolo Fabbri 1/3, 40138, Bologna, Italy.

Emilia Antonucci (E)

Arianna Anticoagulazione" Foundation, Via Paolo Fabbri 1/3, 40138, Bologna, Italy.

Serena Zorzi (S)

Arianna Anticoagulazione" Foundation, Via Paolo Fabbri 1/3, 40138, Bologna, Italy.

Angelo A Bignamini (AA)

Department of Pharmaceutical Sciences, School of Specialization in Hospital Pharmacy, University of Milan, Milan, Italy.

Corrado Lodigiani (C)

Thrombosis and Hemorrhagic Diseases Unit, Humanitas Research Hospital and Humanitas University, Rozzano (Milan), Italy.

Alberto Tosetto (A)

Divisione Di Ematologia, Centro Malattie Emorragiche E Trombotiche, AULSS8 Berica, Vicenza, Italy.

Lorenza Bertù (L)

Centro Di Ricerca Sulle Malattie Tromboemboliche E Le Terapie Antitrombotiche, Università Degli Studi dell'Insubria, Varese, Italy.

Vittorio Pengo (V)

Thrombosis Research Laboratory, Department of Cardiac-Thoracic-Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Sophie Testa (S)

Department of Laboratory Medicine, Haemostasis and Thrombosis Center, AO Istituti Ospitalieri, Cremona, Italy.

Walter Ageno (W)

Dipartimento Di Medicina E Chirurgia, Università Degli Studi Dell'Insubria, Varese, Italy.

Domenico Prisco (D)

DMSC Università Di Firenze, SOD Medicina Interna Interdisciplinare, AOU Careggi, Florence, Italy.

Paolo Prandoni (P)

Arianna Anticoagulazione" Foundation, Via Paolo Fabbri 1/3, 40138, Bologna, Italy.

Daniela Poli (D)

Centro Trombosi, Azienda Ospedaliera Careggi, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH